American Oncology Network to Participate in 11 Sessions at 2026 Community Oncology Alliance Annual Conference
Rhea-AI Summary
American Oncology Network (NYSE:AONC) will speak at the 2026 Community Oncology Alliance Annual Conference, April 28-29 in Orlando. AON leaders will deliver 11 sessions on topics including CAR T, radiopharmaceuticals, clinical trials, payer data, patient advocacy and careers in community oncology. AON will exhibit at booth 207.
Positive
- None.
Negative
- None.
News Market Reaction – AONC
In the Apr 22 session, AONC gained 16.13%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 05 | Practice partnership | Positive | -7.3% | Oncology Consultants joined AON, expanding locations and clinical resources in Texas. |
| Feb 04 | New state partner | Positive | +4.3% | RKV Medical Center became AON’s first Oklahoma partner practice to broaden access. |
| Feb 03 | Physician addition | Positive | +4.3% | Hematology Oncology of Indiana welcomed Dr. Amy Braden to expand oncology services. |
| Jan 21 | Staff expansion | Positive | -36.6% | Genesis Cancer and Blood Institute added endocrinology services via new hires in Arkansas. |
| Jan 15 | Data alliance | Positive | -36.6% | Alliance with MiBA to embed AI-powered real-world data into clinical research. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive network expansion and partnership news has often seen mixed or even negative next-day price reactions.
Over the past few months, American Oncology Network news has centered on expansion and data capabilities. On Jan 15, 2026, a strategic alliance with MiBA aimed to integrate AI-enhanced real-world data. Subsequent releases highlighted new clinicians at Genesis Cancer and Blood Institute on Jan 21, 2026, additional physicians at Hematology Oncology of Indiana on Feb 3, 2026, and new partner practices in Oklahoma and South Texas with RKV Medical Center and Oncology Consultants. Today’s conference participation update fits this ongoing narrative of network growth and innovation in community oncology.
Key Terms
car t medical
radiopharmaceuticals medical
clinical trials medical
bispecific therapies medical
car-t cell therapy medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology
FORT MYERS, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it will participate in 11 speaking sessions at the 2026 Community Oncology Alliance (COA) Annual Conference. The event, themed Innovation in Practice, will take place April 28-29 in Orlando, Florida.
“At AON, we are committed to advancing community oncology through innovation that supports local practices and improves patient outcomes,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee. “The conference provides an important platform to share forward-thinking strategies, from new care delivery models to emerging therapies, that are transforming how care is delivered in community settings. I look forward to hearing AON thought leaders share insights with fellow community oncology colleagues.”
AON leaders will speak on a range of topics, including innovative therapies such as CAR T, the importance of high-quality data for smarter payer contracting, patient advocacy, clinical trials, radiopharmaceuticals, and careers in community oncology. Featured speakers include:
- Stephen “Fred” Divers, MD, AON chief medical officer, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee – The Quality of Community Oncology: Presenting the COA Quality & Value Study
- Alti Rahman, MHA/MBA, CSSBB, AON chief strategy and innovation officer and COA board member – Better Data, Better Decisions: Leveraging Transparency for Smarter Contracting
- Ralph Boccia, MD, FACP, AON medical director of research and oncologist and hematologist at AON partner practice, The Center for Cancer and Blood Disorders – CAR T Comes to Main Street: Expanding Access, Empowering Care. Dr. Boccia will discuss how AON has developed one of the first outpatient community-based T-cell-engaging programs, featuring both outpatient bispecific therapies and CAR-T cell therapy, and how this approach is expanding access to advanced treatments within community clinics.
- Katie Alexander, MS, APRN-CNP, AOCNP, BBA, nurse practitioner at AON partner practice, The Zangmeister Cancer Center, and AON central region APP coordinator – The Value of Innovative Therapies for Patients
- Tyler Fugere, MD, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute – What I Wish I’d Known: First-Year Insights After Fellowship
- James Gilmore, PharmD, AON chief pharmacy and clinical services officer – Access & Affordability in the Era of Innovation: Cellular Therapies in Community Oncology
- Jim Chen, MD, oncologist and hematologist at AON partner practice, Genesis Cancer and Blood Institute – Community Oncology as a Career: Voices from the Frontlines
- Sunshine Maracle, AON national event and partnership manager and physician liaison at AON partner practice, Hope Cancer Care of Nevada – CPAN Advocates in Action
- Guy Messer, AS-NMT, BS-HCM, MBA, AON vice president of radiation and radiology services – Building an Innovative and Financially Sustainable Radiopharmaceutical Program
- Emily Whitman, MD, oncologist and hematologist at AON partner practice, Zangmeister Cancer Center – Multidisciplinary Physician Collaboration Driving Innovation in Community Oncology
- Julio Peguero, MD, medical director of research and oncologist at AON partner practice, Oncology Consultants – Expanding Clinical Trial Access in Community Oncology: Tech Tools and Support Strategies
“AON and COA share a mission to protect and promote independent oncology, while embracing the innovation required to meet the evolving needs of patients,” said Alti Rahman, AON chief strategy and innovation officer and COA board member. “By bringing together leaders from across the country, this conference fosters collaboration and accelerates the adoption of data-driven insights, advanced technologies and new care models that are redefining what is possible in community oncology.”
AON provides comprehensive support services to independent oncology practices, including in-house pharmacy, lab services, revenue-diversifying programs and back-office operations. By partnering with AON, physicians can focus on delivering high-quality, patient-centered care in their communities without relying on hospital systems or third-party providers.
AON will also exhibit at booth 207 during the conference.
For more information about AON, visit AONcology.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d832e063-a9fd-48c4-9498-95ee8d61bfde
Media Contact: Karen Riley Sawyer American Oncology Network Karen.Sawyer@AONcology.com